The extrinsic activation of the NF-κB pathway via APRIL and BAFF provides survival signals in the early stages of MM, whereas during tumour progression, mutations in NF-κB pathway genes can result in autonomous NF-κB pathway activation and reduced dependence on the bone marrow microenvironment [58]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.